California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$83.3 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
FULC Fulcrum Therapeutics, Inc.	$197M	$21,000 0.0% of portfolio	4,496	Q2 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$311M	$21,000 0.0% of portfolio	2,511	Q2 2024 Added 9.88%
TSHA Taysha Gene Therapies, Inc.	$73.5M	$21,000 0.0% of portfolio	12,635	Q2 2024 Reduced 8.26%
GLUE Monte Rosa Therapeutics, Inc.	$225M	$21,000 0.0% of portfolio	3,049	Q2 2024 Reduced 27.58%
MGTX Meira G Tx Holdings PLC	$282M	$20,000 0.0% of portfolio	3,446	Q2 2024 Reduced 18.43%
VNDA Vanda Pharmaceuticals Inc.	$249M	$19,000 0.0% of portfolio	4,130	Q2 2024 Reduced 27.29%
QSI Quantum Si Inc	$135M	$19,000 0.0% of portfolio	7,257	Q2 2024 Reduced 29.06%
ADGI Adagio Therapeutics, Inc.	$505M	$19,000 0.0% of portfolio	5,747	Q2 2024 New
TRVI Trevi Therapeutics, Inc.	$356M	$19,000 0.0% of portfolio	4,497	Q2 2024 Reduced 5.38%
KMPH Kempharm, Inc	$170M	$19,000 0.0% of portfolio	3,895	Q2 2024 Reduced 21.75%
CDXC Chroma Dex Corp.	$420M	$18,000 0.0% of portfolio	3,548	Q2 2024 New
VYGR Voyager Therapeutics, Inc.	$134M	$18,000 0.0% of portfolio	3,333	Q2 2024 Reduced 15.77%
AVIR Atea Pharmaceuticals, Inc.	$239M	$18,000 0.0% of portfolio	5,591	Q2 2024 Reduced 27.46%
ALDX Aldeyra Therapeutics, Inc.	$142M	$18,000 0.0% of portfolio	3,610	Q2 2024 Reduced 22.9%
CCCC C4 Therapeutics, Inc.	$76.3M	$16,000 0.0% of portfolio	4,522	Q2 2024 Reduced 6.06%
OCGN Ocugen, Inc.	$149M	$16,000 0.0% of portfolio	21,171	Q2 2024 Reduced 12.43%
ITOS I Teos Therapeutics, Inc.	$265M	$15,000 0.0% of portfolio	1,967	Q2 2024 Added 1,070.77%
ABSI Absci Corp	$298M	$15,000 0.0% of portfolio	5,787	Q2 2024 New
XOMA Xoma Corp	$272M	$15,000 0.0% of portfolio	582	Q2 2024 Reduced 20.82%
MGNX Macrogenics Inc	$103M	$14,000 0.0% of portfolio	4,454	Q2 2024 Added 957.99%
DSGN Design Therapeutics, Inc.	$221M	$14,000 0.0% of portfolio	2,275	Q2 2024 Reduced 30.94%
THRD Third Harmonic Bio, Inc.	$209M	$14,000 0.0% of portfolio	1,437	Q2 2024 Reduced 26.65%
PROK Prokidney Corp Ord Shs Cl A(Cy	$49.8M	$14,000 0.0% of portfolio	8,311	Q2 2024 Reduced 45.04%
CADL Candel Therapeutics, Inc.	$136M	$14,000 0.0% of portfolio	1,615	Q2 2024 Reduced 11.08%
HRTX Heron Therapeutics, Inc.	$255M	$13,000 0.0% of portfolio	8,507	Q2 2024 Reduced 18.27%
CRDF Cardiff Oncology, Inc.	$125M	$13,000 0.0% of portfolio	3,062	Q2 2024 Reduced 7.28%
NKTR Nektar Therapeutics	$124M	$12,000 0.0% of portfolio	12,936	Q2 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$83.8M	$12,000 0.0% of portfolio	4,141	Q2 2024 Added 1,166.89%
CHRS Coherus Bio Sciences, Inc.	$84.7M	$11,000 0.0% of portfolio	7,976	Q2 2024 Reduced 24.43%
FATE Fate Therapeutics Inc	$133M	$11,000 0.0% of portfolio	7,254	Q2 2024 Added 1,135.91%
MRSN Mersana Therapeutics, Inc.	$36.9M	$11,000 0.0% of portfolio	8,220	Q2 2024 Reduced 26.24%
PGEN Precigen, Inc.	$318M	$11,000 0.0% of portfolio	10,576	Q2 2024 Reduced 13.28%
LRMR Larimar Therapeutics, Inc.	$96.5M	$11,000 0.0% of portfolio	3,048	Q2 2024 Added 16.47%
ADCT Adc Therapeutics Sa	$95.5M	$11,000 0.0% of portfolio	5,994	Q2 2024 Reduced 15.37%
STRO Sutro Biopharma, Inc.	$42.3M	$10,000 0.0% of portfolio	5,932	Q2 2024 Reduced 3.14%
VRCA Verrica Pharmaceuticals Inc.	$327M	$10,000 0.0% of portfolio	1,372	Q2 2024 Reduced 34.64%
FENC Fennec Pharmaceuticals Inc.	$138M	$10,000 0.0% of portfolio	1,698	Q2 2024 Reduced 6.96%
SCPH Sc Pharmaceuticals Inc.	$68.5M	$10,000 0.0% of portfolio	3,013	Q2 2024 Reduced 31.73%
INZY Inozyme Pharma, Inc.	$40.1M	$10,000 0.0% of portfolio	3,746	Q2 2024 Reduced 21.94%
TSVT 2seventy Bio, Inc.	$189M	$10,000 0.0% of portfolio	3,541	Q2 2024 Reduced 29.88%
CMPX Compass Therapeutics, Inc.	$214M	$10,000 0.0% of portfolio	7,390	Q2 2024 Reduced 19.46%
PBYI Puma Biotechnology, Inc.	$132M	$9,000 0.0% of portfolio	2,999	Q2 2024 New
XFOR X4 Pharmaceuticals, Inc	$13.7M	$9,000 0.0% of portfolio	12,176	Q2 2024 Reduced 3.31%
NKTX Nkarta, Inc.	$108M	$9,000 0.0% of portfolio	3,834	Q2 2024 Added 26.12%
CRBU Caribou Biosciences, Inc.	$51.1M	$9,000 0.0% of portfolio	5,961	Q2 2024 Reduced 27.6%
VTYX Ventyx Biosciences, Inc.	$66.7M	$9,000 0.0% of portfolio	4,404	Q2 2024 Reduced 6.42%
ENTA Enanta Pharmaceuticals Inc	$114M	$8,000 0.0% of portfolio	1,456	Q2 2024 Reduced 28.52%
FHTX Foghorn Therapeutics Inc.	$177M	$8,000 0.0% of portfolio	1,830	Q2 2024 Reduced 10.47%
ATOS Atossa Therapeutics, Inc.	$83.6M	$8,000 0.0% of portfolio	9,165	Q2 2024 New
TCRX T Scan Therapeutics, Inc.	$28.6M	$8,000 0.0% of portfolio	2,782	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.